Skip to content

Clinicopathological features of rectal cancer according to the location

Clinicopathological features of rectal cancer according to the location - Clinicopathological features of rectal cancer according to the location

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000011972
Enrollment
200
Registered
2013-10-15
Start date
2013-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Sponsors

Digestive Disease Center, Showa University Nothern Yokohama Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.T1 or T2 rectal cancer 2.Patients who received complete treatment for rectal cancer with surgical resection 3.Written informed consent

Exclusion criteria

Exclusion criteria: 1.Presence of synchronous or metachronous advanced colorectal cancer 2.Presence of malignant diseases in any other organs

Design outcomes

Primary

MeasureTime frame
Lymph node metastasis

Secondary

MeasureTime frame
Age, gender, tumor size, morphology, recurrence rate, invasion rate, vessel permeation, tumor budding, wel or mod/ por or muc component, etc

Countries

Japan

Contacts

Public ContactKATSURO ICHIMASA

Showa University Nothern Yokohama Hospital Digestive Disease Center

ichitommy14@yahoo.co.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026